CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 12:00PM GMT
Release Date Price: R$54.96 (+6.10%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Okay, let's get started. All right. Well, welcome, everyone, to Day 1 of the Barclays Global Healthcare Conference. I'm Steven Valiquette, the health care services analyst here at Barclays.

Pleased to kick things off with CVS Health. With us from the company is Shawn Guertin, the company's CFO. This will be a fireside chat. So I think with that, I guess we'll just dive right in.

Questions & Answers

Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO

Sure.

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Okay, great. So maybe we'll kick off with some topics that -- this first question kind of ties to a lot of the parts of the overall company. And maybe just some of your latest thoughts around the COVID impact from here on out. It's been pretty topical for investors.

Obviously, January was a pretty clear trend with COVID being pretty high. It's obviously

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot